These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1075 related articles for article (PubMed ID: 27158839)

  • 1. Clostridium difficile infection.
    Smits WK; Lyras D; Lacy DB; Wilcox MH; Kuijper EJ
    Nat Rev Dis Primers; 2016 Apr; 2():16020. PubMed ID: 27158839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections.
    Carter GP; Chakravorty A; Pham Nguyen TA; Mileto S; Schreiber F; Li L; Howarth P; Clare S; Cunningham B; Sambol SP; Cheknis A; Figueroa I; Johnson S; Gerding D; Rood JI; Dougan G; Lawley TD; Lyras D
    mBio; 2015 Jun; 6(3):e00551. PubMed ID: 26037121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enterotoxic Clostridia:
    Mileto S; Das A; Lyras D
    Microbiol Spectr; 2019 May; 7(3):. PubMed ID: 31124432
    [No Abstract]   [Full Text] [Related]  

  • 4. Systemic dissemination of Clostridium difficile toxins A and B is associated with severe, fatal disease in animal models.
    Steele J; Chen K; Sun X; Zhang Y; Wang H; Tzipori S; Feng H
    J Infect Dis; 2012 Feb; 205(3):384-91. PubMed ID: 22147798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota in burned patients with Clostridioides difficile infection.
    Shoaei P; Shojaei H; Siadat SD; Moshiri A; Vakili B; Yadegari S; Ataei B; Khorvash F
    Burns; 2022 Aug; 48(5):1120-1129. PubMed ID: 34924229
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Alam MZ; Madan R
    Toxins (Basel); 2024 May; 16(6):. PubMed ID: 38922136
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk factors for Clostridium difficile toxin-positive diarrhea: a population-based prospective case-control study.
    Vesteinsdottir I; Gudlaugsdottir S; Einarsdottir R; Kalaitzakis E; Sigurdardottir O; Bjornsson ES
    Eur J Clin Microbiol Infect Dis; 2012 Oct; 31(10):2601-10. PubMed ID: 22441775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Domestic canines do not display evidence of gut microbial dysbiosis in the presence of Clostridioides (Clostridium) difficile, despite cellular susceptibility to its toxins.
    Stone NE; Nunnally AE; Jimenez V; Cope EK; Sahl JW; Sheridan K; Hornstra HM; Vinocur J; Settles EW; Headley KC; Williamson CHD; Rideout JR; Bolyen E; Caporaso JG; Terriquez J; Monroy FP; Busch JD; Keim P; Wagner DM
    Anaerobe; 2019 Aug; 58():53-72. PubMed ID: 30946985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of toxins in Clostridium difficile infection.
    Chandrasekaran R; Lacy DB
    FEMS Microbiol Rev; 2017 Nov; 41(6):723-750. PubMed ID: 29048477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and clinical characteristics of Clostridium difficile infection in a Korean tertiary hospital.
    Kim J; Pai H; Seo MR; Kang JO
    J Korean Med Sci; 2011 Oct; 26(10):1258-64. PubMed ID: 22022175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease Progression and Resolution in Rodent Models of Clostridium difficile Infection and Impact of Antitoxin Antibodies and Vancomycin.
    Warn P; Thommes P; Sattar A; Corbett D; Flattery A; Zhang Z; Black T; Hernandez LD; Therien AG
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6471-6482. PubMed ID: 27527088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and microbiologic characteristics of tcdA-negative variant Clostridium difficile infections.
    Kim J; Pai H; Seo MR; Kang JO
    BMC Infect Dis; 2012 May; 12():109. PubMed ID: 22571633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The roles of host and pathogen factors and the innate immune response in the pathogenesis of Clostridium difficile infection.
    Sun X; Hirota SA
    Mol Immunol; 2015 Feb; 63(2):193-202. PubMed ID: 25242213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The emerging metabolic view of Clostridium difficile pathogenesis.
    Hryckowian AJ; Pruss KM; Sonnenburg JL
    Curr Opin Microbiol; 2017 Feb; 35():42-47. PubMed ID: 27997854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clostridioides difficile exploits toxin-mediated inflammation to alter the host nutritional landscape and exclude competitors from the gut microbiota.
    Fletcher JR; Pike CM; Parsons RJ; Rivera AJ; Foley MH; McLaren MR; Montgomery SA; Theriot CM
    Nat Commun; 2021 Jan; 12(1):462. PubMed ID: 33469019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Novel Vaccine Containing Binary Toxin for the Prevention of Clostridium difficile Disease with Enhanced Efficacy against NAP1 Strains.
    Secore S; Wang S; Doughtry J; Xie J; Miezeiewski M; Rustandi RR; Horton M; Xoconostle R; Wang B; Lancaster C; Kristopeit A; Wang SC; Christanti S; Vitelli S; Gentile MP; Goerke A; Skinner J; Strable E; Thiriot DS; Bodmer JL; Heinrichs JH
    PLoS One; 2017; 12(1):e0170640. PubMed ID: 28125650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Epidemiology and Risk Factors of
    Yang Z; Huang Q; Qin J; Zhang X; Jian Y; Lv H; Liu Q; Li M
    Front Cell Infect Microbiol; 2020; 10():578098. PubMed ID: 33425775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The microbial metabolite urolithin A reduces
    Ghosh S; Erickson D; Chua MJ; Collins J; Jala VR
    mSystems; 2024 Feb; 9(2):e0125523. PubMed ID: 38193707
    [No Abstract]   [Full Text] [Related]  

  • 19. Human intestinal enteroids as a model of
    Engevik MA; Danhof HA; Chang-Graham AL; Spinler JK; Engevik KA; Herrmann B; Endres BT; Garey KW; Hyser JM; Britton RA; Versalovic J
    Am J Physiol Gastrointest Liver Physiol; 2020 May; 318(5):G870-G888. PubMed ID: 32223302
    [No Abstract]   [Full Text] [Related]  

  • 20. Antimicrobial resistance in large clostridial toxin-negative, binary toxin-positive Clostridium difficile ribotypes.
    Androga GO; Knight DR; Lim SC; Foster NF; Riley TV
    Anaerobe; 2018 Dec; 54():55-60. PubMed ID: 30053486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.